::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

REVIEW STUDY: MANAGEMENT OF LIVER CIRRHOSIS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

AUTHORS:

Johara Abdulrahman Alnafie, Ozuf Nasser Alzahrani, Tareq Jamil Almughalles, Mahajamil alhothly, Shatha Hussain Mohammed Kariri, Ghaida Abdullah Alonayzan

ABSTRACT:

Background: the majority of HCC patients are suffering from cirrhosis thus it’s challenging to manage HCC because it’s associated with chronic dysfunction of the liver. Objective: This study aimed at studying the management procedures for liver cirrhosis among patients with hepatocellular carcinoma. Methods: The online medical database was searched then the English articles from 2010 – 2020 were included in the review. Results: There were 36 studies included that answered the question about the management procedures for liver cirrhosis among patients with hepatocellular carcinoma. Conclusion: liver cirrhosis is a critical illness among HCC patients which hinders the management of HCC and can result in many complications. The severity of the liver disease and decompensation can affect the survival rates thus Child-Pugh is considered a sensitive and prognostic factor for defining the proper management technique among HCC patients. Keywords: Management, liver cirrhosis, hepatocellular carcinoma (HCC).